Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort.

Title: Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort.
Authors: Briggs, Andrew H; Ibbetson, Andrew; Walters, Archie; Houchen-Wolloff, Linzy; Armstrong, Natalie; Emerson, Tristan; Gill, Rhyan; Hastie, Claire; Little, Paul; Overton, Charlotte; Pimm, John; Poinasamy, Krisnah; Singh, Sally; Walker, Samantha; Leavy, Olivia C; Richardson, Matthew; Elneima, Omer; McAuley, Hamish; Shikotra, Aarti; Singapuri, Amisha; Sereno, Marco; Saunders, Ruth M; Harris, Victoria C; Greening, Neil J; Harrison, Ewen; Docherty, Annemarie; Lone, Nazir I; Quint, Jennifer K; Chalmers, James; Ho, Ling-Pei; Horsley, Alex Robert; Raman, Betty; Wain, Louise V; Brightling, Christopher E; Marks, Michael; Evans, Rachael A; PHOSP-COVID Study Collaborative Group
Publisher Information: BMJ
Publication Year: 2025
Collection: London School of Hygiene & Tropical Medicine: LSHTM Research Online
Description: BACKGROUND: Long covid has emerged as a complex health condition for millions of people worldwide following the COVID-19 pandemic. Previously, we have categorised healthcare pathways for patients after discharge from hospital with COVID-19 across 45 UK sites. The aim of this work was to estimate the clinical and cost-effectiveness of these pathways. METHODS: We examined prospectively collected data from 1013 patients at 12 months postdischarge on whether they felt fully recovered (self-report), number of newly diagnosed conditions (NDC), quality of life (EuroQoL-five dimension-five level (EQ-5D-5L) utility score compared with pre-COVID estimate) and healthcare resource costs (healthcare records). An analysis of the cost-effectiveness was performed by combining the healthcare resource cost and 1-year EQ-5D (giving a quality-adjusted life-year (QALY)) using statistical models that accounted for observed confounding. RESULTS: At 1 year, 29% of participants felt fully recovered, and 41% of patients had an NDC. The most comprehensive services, where all patients could potentially access assessment, rehabilitation and mental health services, were more clinically effective when compared with either no service or light touch services (mean (SE) QALY 0.789 (0.012) vs 0.725 (0.026)), with an estimated cost per QALY of £1700 (95% uncertainty interval: dominated to £24 800). CONCLUSION: Our analysis supports the need for proactive, stratified, comprehensive follow-up, particularly assessment and rehabilitation for adults after hospitalisation with COVID-19, showing these services are likely to be both clinically and cost-effective according to commonly accepted thresholds.
Document Type: article in journal/newspaper
File Description: text
Language: English
ISSN: 2052-4439
Relation: https://researchonline.lshtm.ac.uk/id/eprint/4677820/1/Briggs-etal-2025-Clinical-and-cost-effectiveness-of-diverse-posthospitalisation-pathways.pdf; Briggs, Andrew H ORCID logo; Ibbetson, Andrew; Walters, Archie; Houchen-Wolloff, Linzy; Armstrong, Natalie; Emerson, Tristan; Gill, Rhyan; Hastie, Claire; Little, Paul; Overton, Charlotte; +27 more.Pimm, John; Poinasamy, Krisnah; Singh, Sally; Walker, Samantha; Leavy, Olivia C; Richardson, Matthew; Elneima, Omer; McAuley, Hamish; Shikotra, Aarti; Singapuri, Amisha; Sereno, Marco; Saunders, Ruth M; Harris, Victoria C; Greening, Neil JORCID logo; Harrison, Ewen; Docherty, Annemarie; Lone, Nazir IORCID logo; Quint, Jennifer K; Chalmers, JamesORCID logo; Ho, Ling-PeiORCID logo; Horsley, Alex RobertORCID logo; Raman, Betty; Wain, Louise VORCID logo; Brightling, Christopher E; Marks, Michael ORCID logo; Evans, Rachael AORCID logo; and PHOSP-COVID Study Collaborative Group (2025) Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort. BMJ open respiratory research, 12 (1). e003224-e003224. ISSN 2052-4439 DOI:10.1136/bmjresp-2025-003224
DOI: 10.1136/bmjresp-2025-003224
Availability: https://researchonline.lshtm.ac.uk/id/eprint/4677820/; https://doi.org/10.1136/bmjresp-2025-003224
Rights: cc_by_4
Accession Number: edsbas.E83FB837
Database: BASE